Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma

Clinical trial NCT06723457 · RECRUITING

Trial details

NCT number: NCT06723457
Sponsor: Reem Karmali
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder Refractory B-Cell Non-Hodgkin Lymphoma

Start date: 2025-07-25
Primary completion: 2027-02-18
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.